Overview
VERA market data
Price History
VERA price chart · 1M
- O
- 35.97
- H
- 36.36
- L
- 34.15
- C
- 34.95
- Vol
- 94,176.00
- Source
- US equities market feed
- Observed
- Aug 27, 2026, 12:00 AM
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $35.97
- Previous Close
- $36.81
- Day High
- $36.36
- Day Low
- $34.15
- 52 Week High
- $44.83
- 52 Week Low
- $28.87
- 7 Day Return
- +11.95%
- 30 Day Return
- +4.83%
- 90 Day Return
- -1.67%
- 1 Year Return
- -2.48%
- Daily Notional Volume
- $3.3M Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$4.66 Diluted earnings per share over the trailing twelve months.
- Beta
- 1.00 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $21.15 – $56.05 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $2.2B · P/B 5.87.
Company News
Napco Security Technologies Posts Upbeat Q4 Results, Joins Alvotech, Rum Group And Other Big Stocks Moving Higher On MondayBenzinga · Aug 24, 2026, 2:22 PM
Wedbush Reiterates Neutral on Vera Therapeutics, Maintains $34 Price TargetBenzinga · Aug 17, 2026, 1:10 PM
Heartflow, Eton Pharmaceuticals, Nu Holdings And Other Big Stocks Moving Higher On FridayBenzinga · Aug 14, 2026, 1:55 PM
HC Wainwright & Co. Maintains Buy on Vera Therapeutics, Lowers Price Target to $90Benzinga · Aug 12, 2026, 11:33 AM
Wedbush Maintains Neutral on Vera Therapeutics, Lowers Price Target to $34Benzinga · Aug 11, 2026, 1:39 PM
Vera Therapeutics Q2 EPS $(1.52) Beats $(1.61) EstimateBenzinga · Aug 10, 2026, 9:06 PM
Vera Therapeutics Announces Appointment of Nancy Boman as Chief Regulatory Officer and Planned Retirement of William TurnerGlobenewswire Inc · Jul 9, 2026, 12:15 PM
8-K filing — Vera Therapeutics, Inc. (VERA)SEC EDGAR · Jul 9, 2026, 12:00 PM
TD Cowen Maintains Buy on Vera Therapeutics, Raises Price Target to $78Benzinga · Jul 8, 2026, 3:05 PM
Guggenheim Maintains Buy on Vera Therapeutics, Raises Price Target to $76Benzinga · Jul 8, 2026, 1:35 PM